• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Viveve

Viveve Medical raises $3.2m

May 5, 2020 By Sean Whooley

Viveve Medical (NSDQ:VIVE) filed an SEC Form D yesterday to confirm the sale of more than $3.2 million in options, warrants and other rights to acquire other securities. The company made the first sale in the offering on April 20 and has now sold the total offering amount of $3,225,875. There is a sales commission worth […]

Filed Under: Business/Financial News, Funding Roundup, Gynecological, Women's Health Tagged With: Viveve, Viveve Medical

Cutera, Senseonics and more receive Paycheck Protection Program loans

April 27, 2020 By Sean Whooley

A number of medtech companies announced that they received millions of dollars in loans through the Paycheck Protection Program of the Coronavirus Aid, Relief and Economic Security (CARES) Act. Cutera (NSDQ:CUTR), Senseonics (NYSE:SENS), Viveve Medical (NSDQ:VIVE) and Encision (ECIA:ECIA) received approximately $15 million combined through the program administered by the U.S. Small Business Administration amid the COVID-19 pandemic. […]

Filed Under: Business/Financial News, Diabetes, Funding Roundup, Surgical, Women's Health Tagged With: coronavirus, COVID-19, Cutera Inc., Encision Inc., Senseonics, Viveve, Viveve Medical

Viveve looking at ‘stategic alternatives’ after trial misses the mark

April 9, 2020 By Sean Whooley

Viveve Medical (NSDQ:VIVE) announced today that the clinical trial for its cryogen-cooled monopolar radiofrequency (CMRF) technology did not meet its primary endpoint. The company added that it is currently evaluating strategic alternatives and assessing its organization and cost structure following the missed endpoint amid the current COVID-19 pandemic. The Viveve II clinical trial is a multicenter, […]

Filed Under: Clinical Trials, Gynecological, Women's Health Tagged With: Viveve, Viveve Medical

Viveve Medical completes enrollment for study of its stress urinary incontinence treatment

March 4, 2020 By Sean Whooley

Viveve Medical (NSDQ:VIVE) announced that it completed enrollment in a short-term feasibility study for its cryogen-cooled monopolar radiofrequency (CMRF) treatment for stress urinary incontinence (SUI) in women. The international, three-arm study is a prospective, randomized, single-blind clinical trial comparing Viveve’s CMRF treatment and a cryogen-only sham to an inert sham treatment in women with SU. Englewood, […]

Filed Under: Clinical Trials, Gynecological, Women's Health Tagged With: Viveve, Viveve Medical

Viveve Medical prices $10m offering

December 2, 2019 By Sean Whooley

Viveve Medical (NSDQ:VIVE)  entered into an underwriting agreement with Ladenburg Thalmann & Co. to price an offering of approximately $10 million. Last month, the company issued and sold 978,202 Class A units of common stock at a public offering price of $1.55 per unit, according to an SEC Form 8-K filing. It also issued nearly […]

Filed Under: Business/Financial News, Funding Roundup, Gynecological, Women's Health Tagged With: Viveve, Viveve Medical

Facing delisting, Viveve announces $6.76m funding round

August 19, 2019 By Nancy Crotti

Viveve (NSDQ:VIVE) said last week that it is looking to raise up to $6.76 million in a common stock offering, according to a regulatory filing. The stock is being offered at $0.13 per share, which was the last reported sale price of its common stock on August 15, 2019. The actual number of shares issued […]

Filed Under: Business/Financial News, Featured, Gynecological, News Well, Wall Street Beat, Women's Health Tagged With: Viveve

Viveve prices $20m offering

December 10, 2018 By Brad Perriello

Viveve (NSDQ:VIVE) last week priced a follow-on offering worth $20 million. Englewood, Colo.-based Viveve’s eponymous device uses cryogen-cooled monopolar radiofrequency tech designed to treat gynecological conditions. The company said Dec. 6 that it floated 13.3 million shares at $1.50 apiece, for gross proceeds of $20.0 million. The offering includes a 30-day underwriters option on another 2.0 […]

Filed Under: Featured, Funding Roundup, Wall Street Beat, Women's Health Tagged With: Viveve

Viveve launches woman-focused stress urinary incontinence device trial

August 16, 2018 By Fink Densford

Viveve (NSDQ:VIVE) said on Tuesday it launched a trial exploring the safety and efficacy of its cryogen-cooled monopolar radiofrequency tech designed to treat stress urinary incontinence in women. The new Liberate trial will look to enroll 100 subjects at up to 10 sites in Canada, with patients randomized in a two-to-one ratio for active and sham treatments. […]

Filed Under: Clinical Trials, Urology, Women's Health Tagged With: Viveve

Viveve wins FDA nod to continue Viveve II trial

August 8, 2018 By Fink Densford

Viveve (NSDQ:VIVE) said yesterday it won FDA clearance to continue enrollment in its Viveve II trial exploring the safety and efficacy of its Viveve system for improving sexual function in women following vaginal childbirth. The approval came based off sufficient evidence to support continued enrollment and a lack of subject protection concerns which would preclude continuation, the […]

Filed Under: Clinical Trials, Women's Health Tagged With: Viveve

Viveve settles IP suit against Thermigen

June 6, 2018 By Fink Densford

Viveve (NSDQ:VIVE) said this week it inked a settlement and licensing agreement with Thermigen and associated defendants to resolve a patent litigation claiming Thermigen improperly used Viveve intellectual property with its ThermiVa system. The resolution clears up all pending disputes between the companies, according to an SEC filing from Englewood, Colo.-based Viveve, and grants Thermigen a non-exclusive, […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic, Legal News, Patent Infringement Tagged With: Thermi, Viveve

Viveve closes $32m offering

February 12, 2018 By Fink Densford

Viveve (NSDQ:VIVE) said today it closed a $32.4 million offering with funds slated to support continued research and development and commercialization of its products. The Englewood, Colo.-based company said it sold a total of 11.5 million shares of stock at $3 per share, including shares sold during the full exercise of an underwriters option to purchase […]

Filed Under: Business/Financial News, Funding Roundup Tagged With: Viveve

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS